MetaADEDB 2.0 @ LMMD
Breo Ellipta
(IVFHIIPWLILHCX-KVXXQBCDSA-N)
Structure
SMILES
OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O.FCSC(=O)[C@@]1(OC(=O)c2ccco2)[C@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1(C2C[C@@H](C2=CC(=O)C=C[C@]12C)F)F
Molecular Formula:
C51H62Cl2F3NO11S
Molecular Weight:
1025.000
Log P:
9.9258
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
5
TPSA:
210.29
CAS Number(s):
N/A
Synonym(s)
1.
Breo Ellipta
External Link(s)
PubChem Compound71306415
Therapeutic Target DatabaseD00WMK
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Wrong technique in device usage processFAERS: 694US FAERS
2Drug ineffectiveFAERS: 587
Canada Vigilance: 13
Canada Vigilance
US FAERS
3Drug dose omissionFAERS: 513US FAERS
4Device use errorFAERS: 505US FAERS
5Product quality issueFAERS: 476US FAERS
6Drug dispensing errorFAERS: 380US FAERS
7Wrong technique in product usage processFAERS: 294
Canada Vigilance: 2
Canada Vigilance
US FAERS
8DysphoniaFAERS: 263US FAERS
9OverdoseFAERS: 245US FAERS
10Product complaintFAERS: 234
Canada Vigilance: 12
Canada Vigilance
US FAERS
11Product dose omissionFAERS: 215
Canada Vigilance: 1
Canada Vigilance
US FAERS
12Circumstance or information capable of leading to medication errorFAERS: 165US FAERS
13Product label confusionFAERS: 161US FAERS
14MalaiseFAERS: 152
Canada Vigilance: 3
Canada Vigilance
US FAERS
15Product packaging confusionFAERS: 151US FAERS
16Product use in unapproved indicationFAERS: 145US FAERS
17Product use issueFAERS: 143
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Prescribed overdoseFAERS: 134US FAERS
19HeadacheFAERS: 101
Canada Vigilance: 1
Canada Vigilance
US FAERS
20AsthmaFAERS: 99
Canada Vigilance: 2
Canada Vigilance
US FAERS
21PneumoniaFAERS: 96
Canada Vigilance: 14
Canada Vigilance
US FAERS
22DizzinessFAERS: 94
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Intentional product misuseFAERS: 90US FAERS
24Oropharyngeal painFAERS: 88
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Extra dose administeredFAERS: 84US FAERS
26Chest discomfortFAERS: 80
Canada Vigilance: 2
Canada Vigilance
US FAERS
27Inappropriate schedule of drug administrationFAERS: 78US FAERS
28Drug prescribing errorFAERS: 77US FAERS
29WheezingFAERS: 72US FAERS
30Chest PainFAERS: 65US FAERS
31Inability to afford medicationFAERS: 63US FAERS
32Throat irritationFAERS: 60US FAERS
33Productive CoughFAERS: 58US FAERS
34Medication ErrorFAERS: 57US FAERS
35Drug effect incompleteFAERS: 56US FAERS
36FatigueFAERS: 56US FAERS
37Product dispensing errorFAERS: 53US FAERS
38Oral candidiasisFAERS: 52US FAERS
39PalpitationsFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Product storage errorFAERS: 51US FAERS
41TremorFAERS: 49US FAERS
42NauseaFAERS: 47US FAERS
43AstheniaFAERS: 44US FAERS
44Feeling abnormalFAERS: 44US FAERS
45Expired product administeredFAERS: 40US FAERS
46HypersensitivityFAERS: 40US FAERS
47NasopharyngitisFAERS: 40US FAERS
48BronchitisFAERS: 38US FAERS
49Accidental overdoseFAERS: 37US FAERS
50AnxietyFAERS: 37US FAERS
51PainFAERS: 37US FAERS
52Cerebrovascular accidentFAERS: 34US FAERS
53PruritusFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
54Therapeutic response unexpectedFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Drug administration errorFAERS: 32US FAERS
56StomatitisFAERS: 32US FAERS
57UrticariaFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Drug administered to patient of inappropriate ageFAERS: 31US FAERS
59AphoniaFAERS: 30US FAERS
60Intentional product use issueFAERS: 29US FAERS
61Intercepted medication errorFAERS: 29US FAERS
62Back PainFAERS: 27US FAERS
63Myocardial InfarctionFAERS: 27US FAERS
64Oral painFAERS: 27US FAERS
65ArthralgiaFAERS: 26US FAERS
66InfluenzaFAERS: 26US FAERS
67SinusitisFAERS: 26US FAERS
68BronchospasmFAERS: 25US FAERS
69Incorrect dose administeredFAERS: 25US FAERS
70DysgeusiaFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
71Feeling jitteryFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
72NervousnessFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Peripheral swellingFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Visual ImpairmentFAERS: 22US FAERS
75Incorrect product storageFAERS: 21US FAERS
76Intercepted drug prescribing errorFAERS: 21US FAERS
77Secretion dischargeFAERS: 21US FAERS
78Inappropriate schedule of product administrationFAERS: 20US FAERS
79TachycardiaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Adverse eventFAERS: 19US FAERS
81Product prescribing errorFAERS: 19US FAERS
82Atrial FibrillationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Accidental exposure to productFAERS: 17US FAERS
84Circumstance or information capable of leading to device use errorFAERS: 17US FAERS
85LaryngitisFAERS: 17US FAERS
86VomitingFAERS: 17US FAERS
87Blood glucose increasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
88MyalgiaFAERS: 16US FAERS
89Prescription drug used without a prescriptionFAERS: 16US FAERS
90ChokingFAERS: 15US FAERS
91InfectionFAERS: 15US FAERS
92Product taste abnormalFAERS: 15US FAERS
93CataractFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
94Drug ineffective for unapproved indicationFAERS: 13US FAERS
95EpistaxisFAERS: 13US FAERS
96Intentional dose omissionFAERS: 13US FAERS
97Intercepted drug dispensing errorFAERS: 13US FAERS
98Abdominal discomfortFAERS: 12US FAERS
99ChillsFAERS: 12US FAERS
100Diabetes MellitusFAERS: 12US FAERS
101Lower respiratory tract infectionFAERS: 12US FAERS
102Memory impairmentFAERS: 12US FAERS
103Rehabilitation therapyFAERS: 12US FAERS
104RetchingFAERS: 12US FAERS
105SwellingFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
106ConstipationFAERS: 11US FAERS
107Device malfunctionFAERS: 11US FAERS
108DiscomfortFAERS: 11US FAERS
109ErythemaFAERS: 11US FAERS
110Intercepted drug administration errorFAERS: 11US FAERS
111Lip swellingFAERS: 11US FAERS
112AgeusiaFAERS: 10US FAERS
113ArthritisFAERS: 10US FAERS
114Burning sensationFAERS: 10US FAERS
115Cataract operationFAERS: 10US FAERS
116Emergency care examinationFAERS: 10US FAERS
117Intentional device misuseFAERS: 10US FAERS
118Joint swellingFAERS: 10US FAERS
119Oropharyngeal discomfortFAERS: 10US FAERS
120Respiratory tract congestionFAERS: 10US FAERS
121AmnesiaFAERS: 9US FAERS
122Increased upper airway secretionFAERS: 9US FAERS
123AlopeciaFAERS: 8US FAERS
124AngioedemaFAERS: 8US FAERS
125DisorientationFAERS: 8US FAERS
126Eye painFAERS: 8US FAERS
127GlaucomaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
128Oral fungal infectionFAERS: 8US FAERS
129SepsisFAERS: 8US FAERS
130SomnolenceFAERS: 8US FAERS
131ThrombosisFAERS: 8US FAERS
132Tongue discomfortFAERS: 8US FAERS
133Cardiac ArrestFAERS: 7US FAERS
134Choking sensationFAERS: 7US FAERS
135DyspepsiaFAERS: 7US FAERS
136Incorrect dose administered by deviceFAERS: 7US FAERS
137Multiple allergiesFAERS: 7US FAERS
138Nonspecific reactionFAERS: 7US FAERS
139Product availability issueFAERS: 7US FAERS
140Weight decreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Accidental underdoseFAERS: 6US FAERS
142BlindnessFAERS: 6US FAERS
143Device difficult to useFAERS: 6US FAERS
144Emotional distressFAERS: 6US FAERS
145Exposure via ingestionFAERS: 6US FAERS
146FlushingFAERS: 6US FAERS
147Incorrect route of drug administrationFAERS: 6US FAERS
148Increased bronchial secretionFAERS: 6US FAERS
149Macular degenerationFAERS: 6US FAERS
150Mouth swellingFAERS: 6US FAERS
151Musculoskeletal PainFAERS: 6US FAERS
152Poor quality sleepFAERS: 6US FAERS
153Product communication issueFAERS: 6US FAERS
154Respiratory FailureFAERS: 6US FAERS
155SneezingFAERS: 6US FAERS
156SyncopeFAERS: 6US FAERS
157Therapy cessationFAERS: 6US FAERS
158Upper-airway cough syndromeFAERS: 6US FAERS
159Urinary RetentionFAERS: 6US FAERS
160AgitationFAERS: 5US FAERS
161Blood urine presentFAERS: 5US FAERS
162Device use issueFAERS: 5US FAERS
163DysuriaFAERS: 5US FAERS
164Emergency CareFAERS: 5US FAERS
165Eye irritationFAERS: 5US FAERS
166Hip surgeryFAERS: 5US FAERS
167Middle insomniaFAERS: 5US FAERS
168Oxygen supplementationFAERS: 5US FAERS
169Pulmonary EmbolismFAERS: 5US FAERS
170Pulmonary painFAERS: 5US FAERS
171Rash erythematousFAERS: 5US FAERS
172Rotator cuff syndromeFAERS: 5US FAERS
173ScabFAERS: 5US FAERS
174Throat clearingFAERS: 5US FAERS
175Urinary tract infectionFAERS: 5US FAERS
176Abdominal PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Activities of daily living impairedFAERS: 4US FAERS
178AngerFAERS: 4US FAERS
179AnosmiaFAERS: 4US FAERS
180Apparent deathFAERS: 4US FAERS
181CheilitisFAERS: 4US FAERS
182Contraindicated product administeredFAERS: 4US FAERS
183DementiaFAERS: 4US FAERS
184Euphoric moodFAERS: 4US FAERS
185Exposure via skin contactFAERS: 4US FAERS
186FlatulenceFAERS: 4US FAERS
187General physical health deteriorationFAERS: 4US FAERS
188Genital infection fungalFAERS: 4US FAERS
189Head discomfortFAERS: 4US FAERS
190HyperventilationFAERS: 4US FAERS
191HypoxiaFAERS: 4US FAERS
192Loss of personal independence in daily activitiesFAERS: 4US FAERS
193Lower respiratory tract congestionFAERS: 4US FAERS
194Neck PainFAERS: 4US FAERS
195Oral mucosal erythemaFAERS: 4US FAERS
196Oropharyngeal candidiasisFAERS: 4US FAERS
197PancreatitisFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
198Physical product label issueFAERS: 4US FAERS
199Product design confusionFAERS: 4US FAERS
200Pulmonary FibrosisFAERS: 4US FAERS
201SciaticaFAERS: 4US FAERS
202Terminal stateFAERS: 4US FAERS
203Vitreous floatersFAERS: 4US FAERS
204Wrong patient received medicationFAERS: 4US FAERS
205ArthropathyFAERS: 3US FAERS
206BronchiectasisFAERS: 3US FAERS
207CystitisFAERS: 3US FAERS
208Depressed moodFAERS: 3US FAERS
209DermatitisFAERS: 3US FAERS
210Device defectiveFAERS: 3US FAERS
211Dry skinFAERS: 3US FAERS
212Feeling ColdFAERS: 3US FAERS
213Gait inabilityFAERS: 3US FAERS
214Gingival blisterFAERS: 3US FAERS
215Gingival erythemaFAERS: 3US FAERS
216Hospice CareFAERS: 3US FAERS
217HypotensionFAERS: 3US FAERS
218ImmunosuppressionFAERS: 3US FAERS
219Impaired work abilityFAERS: 3US FAERS
220Initial insomniaFAERS: 3US FAERS
221Insurance issueFAERS: 3US FAERS
222Intestinal ObstructionFAERS: 3US FAERS
223Irritable Bowel SyndromeFAERS: 3US FAERS
224Joint injuryFAERS: 3US FAERS
225Limb operationFAERS: 3US FAERS
226LymphadenopathyFAERS: 3US FAERS
227Muscle tightnessFAERS: 3US FAERS
228Musculoskeletal chest painFAERS: 3US FAERS
229Oral infectionFAERS: 3US FAERS
230PneumonectomyFAERS: 3US FAERS
231Prescribed underdoseFAERS: 3US FAERS
232Product administered to patient of inappropriate ageFAERS: 3US FAERS
233Product residue presentFAERS: 3US FAERS
234Product substitution issueFAERS: 3US FAERS
235Respiratory distressFAERS: 3US FAERS
236Respiratory tract irritationFAERS: 3US FAERS
237Therapeutic product effect incompleteFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Tongue blisteringFAERS: 3US FAERS
239Tooth ExtractionFAERS: 3US FAERS
240Unevaluable eventFAERS: 3US FAERS
241Upper respiratory tract congestionFAERS: 3US FAERS
242VertigoFAERS: 3US FAERS
243Viral upper respiratory tract infectionFAERS: 3US FAERS
244cancer surgeryFAERS: 3US FAERS
245colonoscopyFAERS: 3US FAERS
246treatment failureFAERS: 3US FAERS
247AbasiaFAERS: 2US FAERS
248Abdominal cavity drainageFAERS: 2US FAERS
249Accidental exposure to product packagingFAERS: 2US FAERS
250Acute kidney injuryFAERS: 2US FAERS
251Amphetamines positiveFAERS: 2US FAERS
252Angina PectorisFAERS: 2US FAERS
253Ankle FractureFAERS: 2US FAERS
254AphasiaFAERS: 2US FAERS
255AsthenopiaFAERS: 2US FAERS
256Blood cholesterol increasedFAERS: 2US FAERS
257Blood glucose abnormalFAERS: 2US FAERS
258Blood potassium decreasedFAERS: 2US FAERS
259Blood pressure fluctuationFAERS: 2US FAERS
260Bone painFAERS: 2US FAERS
261Breast FeedingFAERS: 2US FAERS
262CholelithiasisFAERS: 2US FAERS
263Cold sweatFAERS: 2US FAERS
264ConjunctivitisFAERS: 2US FAERS
265Croup infectiousFAERS: 2US FAERS
266CryingFAERS: 2US FAERS
267DeafnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
268Dental cariesFAERS: 2US FAERS
269Device breakageFAERS: 2US FAERS
270Device leakageFAERS: 2US FAERS
271DiplopiaFAERS: 2US FAERS
272Drug-disease interactionFAERS: 2US FAERS
273Electrocardiogram QT interval abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
274EructationFAERS: 2US FAERS
275Escherichia infectionFAERS: 2US FAERS
276Facial PainFAERS: 2US FAERS
277FibromyalgiaFAERS: 2US FAERS
278Foreign body in respiratory tractFAERS: 2US FAERS
279Fungal pharyngitisFAERS: 2US FAERS
280Gingival RecessionFAERS: 2US FAERS
281GlossitisFAERS: 2US FAERS
282HungerFAERS: 2US FAERS
283HypersomniaFAERS: 2US FAERS
284Hypertensive crisisFAERS: 2US FAERS
285HypophagiaFAERS: 2US FAERS
286Implantable defibrillator insertionFAERS: 2US FAERS
287Incorrect drug administration durationFAERS: 2US FAERS
288Increased viscosity of bronchial secretionFAERS: 2US FAERS
289Inhalation TherapyFAERS: 2US FAERS
290Intercepted product dispensing errorFAERS: 2US FAERS
291Intercepted product prescribing errorFAERS: 2US FAERS
292Intercepted product selection errorFAERS: 2US FAERS
293LacerationFAERS: 2US FAERS
294Limb discomfortFAERS: 2US FAERS
295Limb injuryFAERS: 2US FAERS
296Lip exfoliationFAERS: 2US FAERS
297Lung carcinoma cell type unspecified stage IIFAERS: 2US FAERS
298Mechanical ventilationFAERS: 2US FAERS
299Medication residue presentFAERS: 2US FAERS
300Mental status changesFAERS: 2US FAERS
301Musculoskeletal stiffnessFAERS: 2US FAERS
302Nasal PolypsFAERS: 2US FAERS
303Nasal discomfortFAERS: 2US FAERS
304NephrolithiasisFAERS: 2US FAERS
305NeuralgiaFAERS: 2US FAERS
306NocturiaFAERS: 2US FAERS
307Ocular discomfortFAERS: 2US FAERS
308Oral dischargeFAERS: 2US FAERS
309Oral mucosal exfoliationFAERS: 2US FAERS
310Oxygen saturation abnormalFAERS: 2US FAERS
311Pain of skinFAERS: 2US FAERS
312PallorFAERS: 2US FAERS
313Pancreatic carcinomaFAERS: 2US FAERS
314Paranasal sinus hypersecretionFAERS: 2US FAERS
315PhotophobiaFAERS: 2US FAERS
316PneumonitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
317PneumothoraxFAERS: 2US FAERS
318PolyuriaFAERS: 2US FAERS
319Product dosage form confusionFAERS: 2US FAERS
320Product package associated injuryFAERS: 2US FAERS
321Product packaging issueFAERS: 2US FAERS
322Product physical issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
323Product preparation errorFAERS: 2US FAERS
324Product use complaintFAERS: 2US FAERS
325Pulmonary congestionFAERS: 2US FAERS
326Pulmonary thrombosisFAERS: 2US FAERS
327RhinalgiaFAERS: 2US FAERS
328RhinitisFAERS: 2US FAERS
329Sinus operationFAERS: 2US FAERS
330Sjogren's SyndromeFAERS: 2US FAERS
331Skin UlcerFAERS: 2US FAERS
332Skin reactionFAERS: 2US FAERS
333SomnambulismFAERS: 2US FAERS
334Spinal column stenosisFAERS: 2US FAERS
335StressFAERS: 2US FAERS
336Supraventricular tachycardiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Therapeutic response delayedFAERS: 2US FAERS
338ThirstFAERS: 2US FAERS
339ThyroidectomyFAERS: 2US FAERS
340TinnitusFAERS: 2US FAERS
341Tobacco userFAERS: 2US FAERS
342Tooth InfectionFAERS: 2US FAERS
343Urinary IncontinenceFAERS: 2US FAERS
344Wound InfectionFAERS: 2US FAERS
345Wrong strengthFAERS: 2US FAERS
346furuncleFAERS: 2US FAERS
347AbscessFAERS: 1US FAERS
348Accidental exposure to product by childFAERS: 1US FAERS
349AcneFAERS: 1US FAERS
350Acute respiratory failureFAERS: 1US FAERS
351Amino acid level increasedFAERS: 1US FAERS
352AneurysmFAERS: 1US FAERS
353Arthropod biteFAERS: 1US FAERS
354AtelectasisFAERS: 1US FAERS
355Atrioventricular BlockFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
356AuraFAERS: 1US FAERS
357Autoimmune PancreatitisFAERS: 1US FAERS
358Bacterial test positiveFAERS: 1US FAERS
359Bed restFAERS: 1US FAERS
360BedriddenFAERS: 1US FAERS
361Biliary ColicFAERS: 1US FAERS
362BlepharitisFAERS: 1US FAERS
363Blood carbon monoxide increasedFAERS: 1US FAERS
364Blood cholesterol abnormalFAERS: 1US FAERS
365Blood glucose decreasedFAERS: 1US FAERS
366Blood glucose fluctuationFAERS: 1US FAERS
367Blood potassium increasedFAERS: 1US FAERS
368Blood sodium decreasedFAERS: 1US FAERS
369Blood triglycerides increasedFAERS: 1US FAERS
370Body temperature fluctuationFAERS: 1US FAERS
371BradycardiaFAERS: 1US FAERS
372Bronchial HyperreactivityFAERS: 1US FAERS
373BruxismFAERS: 1US FAERS
374Buccal mucosal rougheningFAERS: 1US FAERS
375Carbon dioxide increasedFAERS: 1US FAERS
376Cardiac FlutterFAERS: 1US FAERS
377Cardiac ablationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
378Cardiac assistance device userFAERS: 1US FAERS
379Cardiac dysfunctionFAERS: 1US FAERS
380Cardiac valve ruptureFAERS: 1US FAERS
381Carotid artery occlusionFAERS: 1US FAERS
382CatatoniaFAERS: 1US FAERS
383CellulitisFAERS: 1US FAERS
384Cholecystitis infectiveFAERS: 1US FAERS
385ChromaturiaFAERS: 1US FAERS
386ColitisFAERS: 1US FAERS
387Colon cancer recurrentFAERS: 1US FAERS
388Complication associated with deviceFAERS: 1US FAERS
389Congenital cardiovascular anomaly repairFAERS: 1US FAERS
390Continuous Positive Airway PressureFAERS: 1US FAERS
391Conversion disorderFAERS: 1US FAERS
392CystFAERS: 1US FAERS
393Decreased immune responsivenessFAERS: 1US FAERS
394DehydrationFAERS: 1US FAERS
395DeliriumFAERS: 1US FAERS
396Dermatitis acneiformFAERS: 1US FAERS
397Device damageFAERS: 1US FAERS
398Device effect variableFAERS: 1US FAERS
399Device ineffectiveFAERS: 1US FAERS
400Device material issueFAERS: 1US FAERS
401Diffuse alopeciaFAERS: 1US FAERS
402DisabilityFAERS: 1US FAERS
403Discontinued product administeredFAERS: 1US FAERS
404Disease ProgressionFAERS: 1US FAERS
405Disease complicationFAERS: 1US FAERS
406Disease recurrenceFAERS: 1US FAERS
407DissociationFAERS: 1US FAERS
408DiverticulitisFAERS: 1US FAERS
409Drug dispensed to wrong patientFAERS: 1US FAERS
410Drug dispensing issueFAERS: 1US FAERS
411Drug dose omission by deviceFAERS: 1US FAERS
412Drug effect delayedFAERS: 1US FAERS
413Drug effect variableFAERS: 1US FAERS
414Drug effective for unapproved indicationFAERS: 1US FAERS
415Drug screen false positiveFAERS: 1US FAERS
416Drug screen positiveFAERS: 1US FAERS
417Duodenal UlcerFAERS: 1US FAERS
418Duodenogastric RefluxFAERS: 1US FAERS
419DysarthriaFAERS: 1US FAERS
420DyscheziaFAERS: 1US FAERS
421DystoniaFAERS: 1US FAERS
422Ear congestionFAERS: 1US FAERS
423Economic problemFAERS: 1US FAERS
424ElephantiasisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
425Eosinophilic PneumoniaFAERS: 1US FAERS
426Epiglottic erythemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
427EpiglottitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
428EpilepsyFAERS: 1US FAERS
429Exposed bone in jawFAERS: 1US FAERS
430Exposure during breast feedingFAERS: 1US FAERS
431Exposure via breast milkFAERS: 1US FAERS
432Exposure via contaminated deviceFAERS: 1US FAERS
433Exposure via eye contactFAERS: 1US FAERS
434Exposure via inhalationFAERS: 1US FAERS
435Eye InfectionFAERS: 1US FAERS
436Feeding tube userFAERS: 1US FAERS
437Foaming at mouthFAERS: 1US FAERS
438Fracture treatmentFAERS: 1US FAERS
439Gastrointestinal sounds abnormalFAERS: 1US FAERS
440Gastrointestinal stoma complicationFAERS: 1US FAERS
441General symptomFAERS: 1US FAERS
442Genital infectionFAERS: 1US FAERS
443Glaucoma surgeryFAERS: 1US FAERS
444Grip strength decreasedFAERS: 1US FAERS
445Head titubationFAERS: 1US FAERS
446Heart sounds abnormalFAERS: 1US FAERS
447HepatitisFAERS: 1US FAERS
448HepatotoxicityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
449HerniaFAERS: 1US FAERS
450HirsutismFAERS: 1US FAERS
451HyperacusisFAERS: 1US FAERS
452HypokinesiaFAERS: 1US FAERS
453HysterectomyFAERS: 1US FAERS
454Increased viscosity of nasal secretionFAERS: 1US FAERS
455Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
456InfarctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
457Inflammatory marker increasedFAERS: 1US FAERS
458Inspiratory capacity decreasedFAERS: 1US FAERS
459Intention tremorFAERS: 1US FAERS
460Intervertebral Disc DegenerationFAERS: 1US FAERS
461Intervertebral disc disorderFAERS: 1US FAERS
462IritisFAERS: 1US FAERS
463Iron deficiencyFAERS: 1US FAERS
464LagophthalmosFAERS: 1US FAERS
465Large intestinal polypectomyFAERS: 1US FAERS
466Laryngeal erythemaFAERS: 1US FAERS
467Larynx irritationFAERS: 1US FAERS
468LethargyFAERS: 1US FAERS
469LeukopeniaFAERS: 1US FAERS
470Ligament ruptureFAERS: 1US FAERS
471Lip pruritusFAERS: 1US FAERS
472Live BirthFAERS: 1US FAERS
473Living in residential institutionFAERS: 1US FAERS
474Lower respiratory tract infection viralFAERS: 1US FAERS
475LymphomaFAERS: 1US FAERS
476Malignant HypertensionFAERS: 1US FAERS
477Mastication disorderFAERS: 1US FAERS
478Mechanical urticariaFAERS: 1US FAERS
479Meniscus injuryFAERS: 1US FAERS
480Mental impairmentFAERS: 1US FAERS
481Metabolic acidosisFAERS: 1US FAERS
482MetastasisFAERS: 1US FAERS
483Metastatic NeoplasmFAERS: 1US FAERS
484MetrorrhagiaFAERS: 1US FAERS
485Migraine with AuraFAERS: 1US FAERS
486Milk AllergyFAERS: 1US FAERS
487Muscle FatigueFAERS: 1US FAERS
488Muscle strainFAERS: 1US FAERS
489Musculoskeletal discomfortFAERS: 1US FAERS
490Nasal inflammationFAERS: 1US FAERS
491Nerve injuryFAERS: 1US FAERS
492Night sweatsFAERS: 1US FAERS
493No adverse eventFAERS: 1US FAERS
494NoduleFAERS: 1US FAERS
495Nutritional condition abnormalFAERS: 1US FAERS
496ObstructionFAERS: 1US FAERS
497Oral administration complicationFAERS: 1US FAERS
498Oral mucosal eruptionFAERS: 1US FAERS
499Oral pruritusFAERS: 1US FAERS
500Oropharyngeal blisteringFAERS: 1US FAERS
501OsteoporosisFAERS: 1US FAERS
502Ovarian cancer stage IVFAERS: 1US FAERS
503Panic DisorderFAERS: 1US FAERS
504PapuleFAERS: 1US FAERS
505Paranasal sinus discomfortFAERS: 1US FAERS
506Paranasal sinus hyposecretionFAERS: 1US FAERS
507Pericardial effusionFAERS: 1US FAERS
508Personality ChangeFAERS: 1US FAERS
509Personality change due to a general medical conditionFAERS: 1US FAERS
510PetechiaeFAERS: 1US FAERS
511Pharyngitis bacterialFAERS: 1US FAERS
512PharyngitisFAERS: 1US FAERS
513Platelet TransfusionFAERS: 1US FAERS
514Pleural InfectionFAERS: 1US FAERS
515PleurisyFAERS: 1US FAERS
516Pleuritic painFAERS: 1US FAERS
517Post procedural infectionFAERS: 1US FAERS
518PresyncopeFAERS: 1US FAERS
519Product administration errorFAERS: 1US FAERS
520Product appearance confusionFAERS: 1US FAERS
521Product blister packaging issueFAERS: 1US FAERS
522Product container seal issueFAERS: 1US FAERS
523Product depositFAERS: 1US FAERS
524Product label issueFAERS: 1US FAERS
525Product name confusionFAERS: 1US FAERS
526Product packaging quantity issueFAERS: 1US FAERS
527Product physical consistency issueFAERS: 1US FAERS
528Product prescribing issueFAERS: 1US FAERS
529Product selection errorFAERS: 1US FAERS
530Product shape issueFAERS: 1US FAERS
531Product supply issueFAERS: 1US FAERS
532Product used for unknown indicationFAERS: 1US FAERS
533Psychiatric symptomFAERS: 1US FAERS
534Pulmonary function test decreasedFAERS: 1US FAERS
535PurpuraFAERS: 1US FAERS
536RalesFAERS: 1US FAERS
537RegurgitationFAERS: 1US FAERS
538Renal cystFAERS: 1US FAERS
539Respiratory TherapyFAERS: 1US FAERS
540Respiratory arrestFAERS: 1US FAERS
541Respiratory tract infection viralFAERS: 1US FAERS
542Restless Legs SyndromeFAERS: 1US FAERS
543RestlessnessFAERS: 1US FAERS
544Retinal Artery OcclusionFAERS: 1US FAERS
545Retinal Vein OcclusionFAERS: 1US FAERS
546Rheumatoid ArthritisFAERS: 1US FAERS
547RosaceaFAERS: 1US FAERS
548SarcoidosisFAERS: 1US FAERS
549Sensation of blood flowFAERS: 1US FAERS
550Septic ShockFAERS: 1US FAERS
551SilicosisFAERS: 1US FAERS
552Skin lacerationFAERS: 1US FAERS
553Skin texture abnormalFAERS: 1US FAERS
554Skin tightnessFAERS: 1US FAERS
555Sleep TalkingFAERS: 1US FAERS
556Soft tissue massFAERS: 1US FAERS
557Somatic symptom disorderFAERS: 1US FAERS
558Spirometry abnormalFAERS: 1US FAERS
559Steroid withdrawal syndromeFAERS: 1US FAERS
560Sudden deathFAERS: 1US FAERS
561Suppressed lactationFAERS: 1US FAERS
562Suspected product tamperingFAERS: 1US FAERS
563Symmetrical drug-related intertriginous and flexural exanthemaFAERS: 1US FAERS
564Symptom recurrenceFAERS: 1US FAERS
565Teeth brittleFAERS: 1US FAERS
566TensionFAERS: 1US FAERS
567Therapeutic procedureFAERS: 1US FAERS
568Therapeutic product effect decreasedFAERS: 1US FAERS
569Therapeutic product effective for unapproved indicationFAERS: 1US FAERS
570Therapy changeFAERS: 1US FAERS
571Thermal burnFAERS: 1US FAERS
572Throat cancerFAERS: 1US FAERS
573Thyroid NeoplasmFAERS: 1US FAERS
574Tinea PedisFAERS: 1US FAERS
575Tongue erythemaFAERS: 1US FAERS
576Tongue fungal infectionFAERS: 1US FAERS
577Tongue pruritusFAERS: 1US FAERS
578Tooth ErosionFAERS: 1US FAERS
579ToothacheFAERS: 1US FAERS
580UnemploymentFAERS: 1US FAERS
581Upper respiratory fungal infectionFAERS: 1US FAERS
582Upper respiratory tract inflammationFAERS: 1US FAERS
583Urinary tract infection fungalFAERS: 1US FAERS
584Urine output increasedFAERS: 1US FAERS
585VertebroplastyFAERS: 1US FAERS
586Violence-related symptomFAERS: 1US FAERS
587Vulvovaginal burning sensationFAERS: 1US FAERS
588Vulvovaginal mycotic infectionFAERS: 1US FAERS
589Vulvovaginal pruritusFAERS: 1US FAERS
590Waist circumference increasedFAERS: 1US FAERS
591Walking aid userFAERS: 1US FAERS
592White blood cell count abnormalFAERS: 1US FAERS
593Wrong patient received productFAERS: 1US FAERS
594Wrong technique in drug usage processFAERS: 1US FAERS
595intensive careFAERS: 1US FAERS
596muscle injuryFAERS: 1US FAERS
597nervous system disorderFAERS: 1US FAERS
598Therapeutic product effect variableCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.